Autori: Zaric Bojan
Naslov | Prevalence of respiratory symptoms and lung diseases in lung cancer screening program (Meeting Abstract) |
Autori | Djekic-Malbasa Jelena N Kovacevic Tomi S Milenkovic Ana M Zaric Bojan Stojanovic Goran Bokan Darijo |
Info | EUROPEAN RESPIRATORY JOURNAL, (2023), vol. 62 br. , Suppl. 67, str. - |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
Naslov | Results and challenges of lung cancer screening in Serbia (Meeting Abstract) |
Autori | Djekic-Malbasa Jelena N Kovacevic Tomi S Zaric Bojan Bokan Darijo Dragisic Dragan Stojanovic Goran |
Info | EUROPEAN RESPIRATORY JOURNAL, (2023), vol. 62 br. , Suppl. 67, str. - |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
Naslov | Improving the Lives of Patients Diagnosed with Lung Carcinoma: The Holistic Power of Palliative Care (Meeting Abstract) |
Autori | Kovacevic Tomi S Zaric Bojan Bursac Daliborka S Djekic-Malbasa Jelena N Stojanovic Goran Bokan Darijo |
Info | JOURNAL OF THORACIC ONCOLOGY, (2023), vol. 18 br. 11, Suppl. S, str. S728-S728 |
Ispravka | ISI/Web of Science Elečas Rang časopisa |
Naslov | Influence of psychiatric disorders on survival in patients with lung cancer: Real-world data (Meeting Abstract) |
Autori | Kovacevic Tomi S Bokan Darijo Djekic-Malbasa Jelena N Zaric Bojan Bursac Daliborka S Stojanovic Goran Simurdic Petar V Stojsic Vladimir N |
Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. S1090-S1090 |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
Naslov | Management of paresthesia in patients treated with lazertinib: Integrated analysis of LASER201 and LASER301 studies (Meeting Abstract) |
Autori | Lee Y-G ... Zaric Bojan ... (broj koautora 16) |
Info | ANNALS OF ONCOLOGY, (2023), vol. 34 br. , Suppl. 2, str. - |
Projekat | Yuhan |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
Naslov | Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301 (Article) |
Autori | Cho Byoung Chul ... Zaric Bojan |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2023), vol. 41 br. 26, str. 4208-+ |
Projekat | The authors would like to thank all the patients who participated in this study and their families and caregivers. The authors would also like to thank the physicians and nurses who cared for the patients and the staff at the clinical sites. |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
Naslov | Real-world data on survival outcomes and characteristics of lung cancer patients in northern serbia. (Meeting Abstract) |
Autori | Bokan Darijo Zaric Bojan Kovacevic Tomi S Stojanovic Goran Djekic-Malbasa Jelena N |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2023), vol. 41 br. 16, Suppl. S, str. - |
Ispravka | ISI/Web of Science Elečas Rang časopisa |
Naslov | Decade of lung cancer in Serbia: tobacco abuse and gender differences (Article) |
Autori | Djekic-Malbasa Jelena N Kovacevic Tomi S Zaric Bojan Dugandzija Tihomir Nikolin Borislava Radovanovic Dragana R Paut-Kusturica Milica M |
Info | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, (2023), vol. 27 br. 7, str. 3105-3116 |
Projekat | Provincial Secretariat for Higher Education and Scientific Research project [142- 451-2621/2021-01] |
Ispravka | ISI/Web of Science Elečas Rang časopisa |
Naslov | Prognostic Role of Monocyte Distribution Width, CRP, Procalcitonin and Lactate as Sepsis Biomarkers in Critically Ill COVID-19 Patients (Article) |
Autori | Bajic Dejana D Matijasevic Jovan A Andrijevic Ljiljana N Zaric Bojan Lalic-Popovic Mladena N Andrijevic Ilija Todorovic Nemanja B Mihajlovic Andrea N Tapavicki Borislav Ostojic Jelena V |
Info | JOURNAL OF CLINICAL MEDICINE, (2023), vol. 12 br. 3, str. - |
Projekat | Project of the Ministry of Education, Science and Technological Development, Provincial Secretariat for Higher Education and Scientific Research, Autonomous Province of Vojvodina, Republic of Serbia [142-451-3176/2022-01] |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
Naslov | A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) (Meeting Abstract) |
Autori | Cho Byoung Chul ... Zaric Bojan |
Info | ANNALS OF ONCOLOGY, (2022), vol. 38 br. 9, Suppl. 9, str. S1560-S1560 |
Projekat | Yuhan Corporation |
Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |